09.09.2021 • NewsAvantor

Avantor Expanding in Polish and US Markets

As part of an investment in its global hydration capabilities, US CDMO Avantor recently completed a major expansion of its production facility at Gliwice, Poland – the company’s European manufacturing flagship – and has begun a multi-stage expansion of the plant at Aurora, Ohio, USA, due to be completed by mid-2022.

Adding to its existing WFI-quality water buffer manufacturing capabilities, Avantor said the investments will dramatically increase its capacity to support biopharma manufacturers worldwide, especially as the Polish site was designed with built-in flexibility to expand capacity as the business grows.

The additional capacity at both sites will enhance the quality of its services, the company added. This, it said, can help customers in the biopharma industry reduce the cost and time to manufacture therapies, including monoclonal antibodies and vaccines, at scale and thus enable greater workflow efficiencies and increase speed to market of new and existing therapies.

Ger Brophy, executive vice president of biopharma production at Avantor, said the CDMO’s investments in its global hydration offering will allow it to strengthen its cGMP chemical manufacturing capability in Europe and the US. Alongside Europe, the Gliwice facility also supports customers in Asia. Upon completion, the Aurora plant will offer expanded support to North America.

Author: Dede Williams, Freelance Journalist

US CDMO Avantor is investing in its global hydration capabilities. After...
US CDMO Avantor is investing in its global hydration capabilities. After completing a major expansion in Poland, it is building new capacity in the US up to 2022. The company said the investments will dramatically increase its capacity to support global biopharma manufacturers. (c) Testalize.me

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation